SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 424B4 - Prospectus [Rule 424(b)(4)]:
SEC Accession No. 0001213900-18-009822
Filing Date
2018-07-30
Accepted
2018-07-30 07:32:00
Documents
13

Document Format Files

Seq Description Document Type Size
1 PROSPECTUS SUPPLEMENT f424b4072618_adialpharma.htm 424B4 2173012
2 GRAPHIC image001.jpg GRAPHIC 24934
3 GRAPHIC image002.jpg GRAPHIC 49675
4 GRAPHIC image003.jpg GRAPHIC 54696
5 GRAPHIC image004.jpg GRAPHIC 160586
6 GRAPHIC image007.jpg GRAPHIC 160699
7 GRAPHIC image008.jpg GRAPHIC 69158
8 GRAPHIC image009.jpg GRAPHIC 49675
9 GRAPHIC image010.jpg GRAPHIC 54696
10 GRAPHIC image_004.jpg GRAPHIC 34558
11 GRAPHIC image_005.jpg GRAPHIC 39732
12 GRAPHIC image014.jpg GRAPHIC 11261
13 GRAPHIC logo.jpg GRAPHIC 24934
  Complete submission text file 0001213900-18-009822.txt   3187510
Mailing Address 1180 SEMINOLE TRAIL SUITE 495 CHARLOTTESVILLE VA 22902
Business Address 1180 SEMINOLE TRAIL SUITE 495 CHARLOTTESVILLE VA 22902 434-422-9800
ADIAL PHARMACEUTICALS, INC. (Filer) CIK: 0001513525 (see all company filings)

IRS No.: 800667150 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 424B4 | Act: 33 | File No.: 333-220368 | Film No.: 18976083
SIC: 2834 Pharmaceutical Preparations